Leuprolide acetate for injection is used to treat the symptoms associated with advanced prostate cancer by way of palliative treatment of advanced prostatic cancer.
Ascend was recognized as a First Merit finalist in the Best Overall Generic Pharmaceutical Product Manufacturer with more than $100 million in sales category.